Sort
82,697 grants matching “vaccine development”
Living in the post-Zika world: Impact of interactions between dengue and Zika viruses on diagnostics, antibody dynamics, and correlates of disease risk
$949,552Eva Harris · University Of California Berkeley · U01 · FY2025 · AI
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$949,519Gary Fanger · Rise Therapeutics, Llc · R44 · FY2020 · DE
Chemically Programmed Immunity
$949,500Carlos F Barbas · Scripps Research Institute, The · DP1 · FY2010 · OD
Process and Assay Development for cGMP Production and Characterization of a VSV-HIV Vaccine Candidate
$949,225Eddy Sayed · International Aids Vaccine Initiative · N01 · FY2019 · AI
Advanced testing of a hexavalent adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment
$949,201Hilliard Kutscher · Pop Biotechnologies, Inc · R44 · FY2025 · AI
Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure
$948,892Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · AI
Clinical Trials of Haploidentical Hematopoietic Stem Cell Transplantation and Vac
$948,884Nelson J. Chao · Duke University · P01 · FY2011 · CA
Operations and Management
$948,744Dennis R. Burton · Scripps Research Institute, The · UM1 · FY2012 · AI
Development of PSMA -based recombinant protein vaccines
$948,449Progenics Pharmaceuticals, Inc. · R44 · FY2004 · CA
A dual vaccine strategy against filovirus infection
$948,391Richard W Compans · Emory University · R01 · FY2013 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$948,345Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI
A Cytomegalovirus-based therapeutic vaccine against oncogenic human papillomaviruses
$948,184Eric Bruening · Tomegavax, Inc. · R44 · FY2016 · CA
The functional significance of CTL escape
$948,180David I Watkins · University Of Miami School Of Medicine · R01 · FY2019 · AI
Assessing Safety of Cell Substrates and Vaccine Components
$948,167National Institute Of Allergy And Infectious Diseases · Y01 · FY2010 · AI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network
$948,068James L. Sorensen · University Of California, San Francisco · UG1 · FY2018 · DA
ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS
$948,056Children'S Research Institute · U01 · FY2001 · HD
Fc effector function in bNAbs
$947,985Jeffrey Victor Ravetch · California Institute Of Technology · P01 · FY2014 · AI
Defining the immunogenic landscape of early mosquito-stage P. falciparum to accelerate malaria transmission-blocking vaccine discovery
$947,948Kristian Edward Swearingen · Institute For Systems Biology · R01 · FY2025 · AI
Development of highly potent human monoclonal for RSV immuno-prophylaxis
$947,868Larry Zeitlin · Mapp Biopharmaceutical, Inc. · R44 · FY2022 · AI
Development Of Vaccines For Genital Herpes Simplex Infection
$947,827Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$947,701Gary Fanger · Rise Therapeutics, Llc · SB1 · FY2023 · DE
Inhibitors and Probes of HIV-1 Cell Fusion
$947,627Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$947,589Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA
Glycan dependent epitopes of HIV broadly neutralizing antibodies
$947,498James C. Paulson · Scripps Research Institute, The · R01 · FY2015 · AI
Glycan dependent epitopes of HIV broadly neutralizing antibodies
$947,498James C. Paulson · Scripps Research Institute, The · R01 · FY2014 · AI